WHO – Oral Cancer News

NCI-designated Cancer Centers Urge HPV Vaccination for the Prevention of Cancer

Source: www.medicine.wustl.eduAuthor: Washington University School of Medicine in St. Louis Staff Approximately 79 million people in the United States are currently infected with a human papillomavirus (HPV) according to the Centers for Disease Control and Prevention (CDC), and 14 million new infections occur each year. Several types of high-risk HPV are responsible for the vast majority of cervical, anal, oropharyngeal (middle throat) and other genital cancers. The CDC also reports that each year in the U.S., 27,000 men and women are diagnosed with an HPV-related cancer, which amounts to a new case every 20 minutes. Even though many of these HPV-related cancers are preventable with a safe and effective vaccine, HPV vaccination rates across the U.S. remain low. Together we, a group of the National Cancer Institute (NCI)- designated Cancer Centers, recognize these low rates of HPV vaccination as a serious public health threat. HPV vaccination represents a rare opportunity to prevent many cases of cancer that is tragically underused. As national leaders in cancer research and clinical care, we are compelled to jointly issue this call to action. According to a 2015 CDC report, only 40 percent of girls and 21 percent of boys in the U.S. are receiving the recommended three doses of the HPV vaccine. This falls far short of the goal of 80 percent by the end of this decade, set forth by the U.S. Department of Health and Human Service’s Healthy People 2020 mission. Furthermore, U.S. rates are significantly lower than those of countries such as [...]

Charlotte Parker2016-02-04T12:35:06-07:00February, 2016|Oral Cancer News|

India ranks first in number of oral cancer cases: World Health Organization report

Source: www.newkerala.com Author: staff India has the highest number of oral cancer cases in the world out of which 90 per cent have been reported due to tobacco-related diseases, according to a World Health Organisation (WHO) survey report. The report said more than 2,200 Indians die each day from a tobacco-related cases and in 2010, an estimated ten lakh people will die due to the killer disease. Every day, 55,000 Indian youths start tobacco use, the report further said. In view of the growing tobacco menace, a one-day Media Advocacy Workshop on Tobacco Control was jointly organised by Itanagar Press Club (IPC) and Voluntary Health Association of India (VHAI) here recently. In the meeting both the print and electronic media unanimously observed that strict enforcement of section 4 of the Cigarettes and Other Tobacco Products (Prohibition of Advertisement and Regulation of Trade and Commerce, Production, Supply and Distribution) Act, 2003, should be ensured. Highlighting different aspects of tobacco in terms of health hazards and socio-economic impact, epidemiologist Dr L Jampa informed that India is the second largest consumer and is placed third in respect of tobacco production. He informed that in 17 out of 29 states of India, tobacco use is more than 69 per cent. The Northeastern region exhibits highest rates of tobacco use - in Mizoram more than 80 per cent of men use some form of tobacco, followed by Tripura (76 per cent) and Assam (72). Arunachal Pradesh is the second largest state whos people chew tobacco [...]

Oral Cancer Foundation News Team - A2010-01-12T12:21:00-07:00January, 2010|Oral Cancer News|

Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States

Source: CEBP.com Author: Staff Requests for reprints: Graça M. Dores, Medical Service (111), Department of Veterans Affairs Medical Center, 921 North East 13th Street, Oklahoma City, OK 73104. Phone: 405-456-3325. E-mail: [email protected] Abstract Background: Carcinomas of the major salivary glands (M-SGC) comprise a morphologically diverse group of rare tumors of largely unknown cause. To gain insight into etiology, we evaluated incidence of M-SGC using the WHO classification schema (WHO-2005). Methods: We calculated age-adjusted incidence rates (IR) and IR ratios (IRR) for M-SGC diagnosed between 1992 and 2006 in the Surveillance, Epidemiology and End Results Program. Results: Overall, 6,391 M-SGC (IR, 11.95/1,000,000 person-years) were diagnosed during 1992 to 2006. Nearly 85% of cases (n = 5,370; IR, 10.00) were encompassed within WHO-2005, and among these, males had higher IRs than females [IRR, 1.51; 95% confidence interval (95% CI), 1.43-1.60]. Squamous cell (IR, 3.44) and mucoepidermoid (IR, 3.23) carcinomas occurred most frequently among males, whereas mucoepidermoid (IR, 2.67), acinic cell (IR, 1.57), and adenoid cystic (IR, 1.40) carcinomas were most common among females. Mucoepidermoid, acinic cell, and adenoid cystic carcinomas predominated in females through age ∼50 years; thereafter, IRs of acinic cell and adenoid cystic carcinomas were nearly equal among females and males, whereas IRs of mucoepidermoid carcinoma among males exceeded IRs among females (IRR, 1.57; 95% CI, 1.38-1.78). Except for mucoepidermoid and adenoid cystic carcinomas, which occurred equally among all races, other subtypes had significantly lower incidence among Blacks and Asians/Pacific Islanders than among Whites. Adenoid cystic carcinoma occurred equally in [...]

Charlotte Parker2009-11-09T13:55:37-07:00November, 2009|Oral Cancer News|

Smokeless tobacco ups oral cancer risk 80 pct – WHO

Source: in.reuters.com Author: staff Chewing tobacco and snuff are less dangerous than cigarettes but the smokeless products still raise the risk of oral cancer by 80 percent, the World Health Organisation's cancer agency said on Tuesday. The review of 11 studies worldwide showed people who chewed tobacco and used snuff also had a 60 percent higher risk of oesophagus and pancreatic cancer. The researchers sought to quantify the risk of smokeless tobacco after a number of studies differed on just how dangerous the products were, said Paolo Boffetta, an epidemiologist at the WHO's International Agency for Research on Cancer. "What we did was try to quantify the burden of smokeless cancer," he said in a telephone interview. "This has never been attempted in such a systematic way before." The researchers, who published their findings in Lancet Oncology, did this by looking at population-wide studies and trials of both humans and animals. They found frequency of use varies greatly both across and within countries, depending on sex, age, ethnic origin and economic background, and were highest in the United States, Sweden and India. They also found that while snuff and chew were less dangerous than smoking because they were not linked to lung cancer, getting cigarette users to switch was not good public policy. "If all smokers did this there would be a net benefit," Boffetta said. "The point is we don't know whether this would happen and there is no data to suggest these smokers would stop or switch."

Webmaster2009-01-28T15:29:47-07:00January, 2009|Oral Cancer News|